Importantly, IL-2 and IL-12 levels are significantly higher in patients with asymptomatic and mild COVID-19 versus moderate and severe disease, while IL-6 levels are correlated with increased severity and poor outcomes in COVID-19 (19, 20). The gene discussed is IL6; the disease is COVID-19.